Article info

Download PDFPDF
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Ignace Vergote, MD, PhD, University Hospitals, Leuven, European Union. E-mail: ignace.vergote{at}uz.kuleuven.ac.be.

Citation

Vergote I, Finkler NJ, Hall JB, et al
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

Publication history

  • Received January 2, 2010
  • First published June 1, 2010.
Online issue publication 
June 01, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.